Breast cancer: Noninvasive and special situations Journal Article
| Authors: | Carlson, R. W.; Allred, D. C.; Anderson, B. O.; Burstein, H. J.; Carter, W. B.; Edge, S. B.; Erban, J. K.; Farrar, W. B.; Forero, A.; Giordano, S. H.; Goldstein, L. J.; Gradishar, W. J.; Hayes, D. F.; Hudis, C. A.; Ljung, B. M.; Marcom, P. K.; Mayer, I. A.; McCormick, B.; Pierce, L. J.; Reed, E. C.; Smith, M. L.; Somlo, G.; Topham, N. S.; Ward, J. H.; Winer, E. P.; Wolff, A. C. |
| Article Title: | Breast cancer: Noninvasive and special situations |
| Abstract: | The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, no single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients. © JNCCN-Journal of the National Comprehensive Cancer Network. |
| Keywords: | histopathology; review; doxorubicin; fluorouracil; placebo; cancer combination chemotherapy; cancer risk; drug safety; adjuvant therapy; cancer adjuvant therapy; cancer radiotherapy; cancer staging; nuclear magnetic resonance imaging; lymph node metastasis; antineoplastic agent; lymph node dissection; neoplasm staging; drug inhibition; cancer prevention; chemoprophylaxis; computer assisted tomography; breast cancer; cystosarcoma phylloides; mastectomy; lorazepam; epidermal growth factor receptor 2; nccn clinical practice guidelines; cyclophosphamide; dexamethasone; kidney failure; practice guideline; breast neoplasms; cancer hormone therapy; chemotherapy induced emesis; mammography; breast carcinoma; carcinoma in situ; ondansetron; tamoxifen; pregnancy; radiation therapy; drug metabolism; estrogen receptor; progesterone receptor; trastuzumab; risk reduction; venlafaxine; citalopram; intraductal carcinoma; paget nipple disease; carcinoma, intraductal, noninfiltrating; breast biopsy; endocrine therapy; ductal carcinoma in situ; lobular carcinoma in situ; raloxifene; serotonin uptake inhibitor; breast-conserving therapy; nccn guidelines; breast fibroadenoma; noninvasive breast cancer; fetus malformation; oligohydramnios; teratogenicity |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 8 |
| Issue: | 10 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2010-10-01 |
| Start Page: | 1182 |
| End Page: | 1207 |
| Language: | English |
| PUBMED: | 20971842 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "Source: Scopus" |
Citation Impact
Related MSK Work